Literature DB >> 21652242

A comparison of the clinical features of fibromyalgia syndrome in different settings.

Winfried Häuser1, Werner Biewer, Mechthild Gesmann, Hedi Kühn-Becker, Frank Petzke, Hubertus von Wilmoswky, Jost Langhorst, Heide Glaesmer.   

Abstract

BACKGROUND: The "funnel hypothesis" of fibromyalgia syndrome (FMS) assumes that the high levels of somatic and psychological symptoms reported by FMS-patients are due to a selection bias of patients seeking for medical specialist care. We tested the hypothesis by comparing FMS-patients from a general population sample and different clinical settings.
METHODS: From a cross-sectional survey of a representative sample of the German general population, persons meeting FMS-criteria were selected. Consecutive in- and outpatients from German rheumatology, pain medicine, psychosomatic medicine and integrative medicine settings with established or initial diagnosis of FMS were recruited. FMS was diagnosed in all samples by the survey criteria of the regional pain scale. Somatic symptom intensity was measured by 13 items of the Patient Health Questionnaire PHQ 15, depressed mood by the 9-items PHQ 9.
RESULTS: 96 persons of the general population, 86 of the rheumatology, 80 of the pain medicine, 69 of the psychosomatic medicine and 58 of the integrative medicine setting were included into the comparison. Patients of the clinical settings reported more pain sites and more somatic and depressive symptoms than FMS-persons of the general population. Patients of the different clinical settings did not differ in the number of pain sites and the intensity of depressive and somatic symptoms.
CONCLUSIONS: We found a "funnel" between FMS-persons of the general population and FMS-patients of clinical settings, but not between patients of different levels of care. Patients contacting the health care system did not differ in clinical features.
Copyright © 2011 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21652242     DOI: 10.1016/j.ejpain.2011.05.008

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  5 in total

1.  Fibromyalgia comorbidity in a community sample of adults with migraine.

Authors:  Dawn A Marcus; Amrita Bhowmick
Journal:  Clin Rheumatol       Date:  2013-06-07       Impact factor: 2.980

2.  [German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].

Authors:  W Häuser; E Jung; B Erbslöh-Möller; M Gesmann; H Kühn-Becker; F Petermann; J Langhorst; T Weiss; R Thoma; A Winkelmann
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

3.  [Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties].

Authors:  A Galek; B Erbslöh-Möller; V Köllner; H Kühn-Becker; J Langhorst; F Petermann; U Prothmann; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

4.  Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials.

Authors:  Kurt Kroenke; Jingwei Wu; Zhangsheng Yu; Matthew J Bair; Jacob Kean; Timothy Stump; Patrick O Monahan
Journal:  Psychosom Med       Date:  2016 Jul-Aug       Impact factor: 4.312

5.  Personality and fibromyalgia syndrome.

Authors:  Katrina Malin; Geoffrey O Littlejohn
Journal:  Open Rheumatol J       Date:  2012-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.